Written by ：Tai Hong、Wei Jie

Translated by ：Cheng Cheng

In recent years, the Central Committee of the Central Committee of the Communist Party of China (“CPC”) with General Secretary Xi Jinping at the core leader has repeatedly stressed that “innovation is the first driving force to lead development, and protection of intellectual property rights is to protect innovation”, especially “to accelerate the construction of intellectual property rights protection system in emerging fields and business types.”  As an important industry related to public health, the Central Committee of the CPC and the State Council have also proposed to promote relevant innovations and set up a supporting protection mechanism in intellectual property in several documents such as the Opinions on Deepening the Reform of the Evaluation and Approval Systems and Encouraging Innovation on Drugs and Medical Devices and the Opinions on Strengthening the Protection of Intellectual Property Rights.   Among them, under the purposes of “promoting structural adjustment and technology innovation in drug and medical device industries, improving industrial competitiveness” and “protecting the lawful rights and interests of patentees, reducing the risks of patent infringements by generic drugs, and encouraging the development of generic drugs”, exploring and establishing a drug patent linkage system has become an important task repeatedly mentioned. Continue Reading Preliminary Discussion on Chinese Drug Patent Linkage System